A top Pfizer Inc scientist said on Thursday the company is in intensive discussions with regulators to test a booster shot version of its coronavirus vaccine specifically...
TheΒ Serum Institute of India (SII)Β will ship theΒ Oxford University/AstraZenecaΒ COVID-19 vaccine to Canada in less than one month, Serum’s chief executive said on Monday.“As we await regulatory...
BioNTechΒ CEO Ugur Sahin said on Monday he was confident a COVID-19 vaccine co-developed by his company would be effective against a variant of the coronavirus...
The Oxford University vaccine against COVID-19 being produced byΒ AstraZenecaΒ is likely to get regulatory approval from the UK’s independent regulator by the end of this year...
Russiaβs sovereign wealth fund,Β Russian Direct Investment Fund (RDIF)Β has joined hands with Indian pharma companyΒ Hetero LabsΒ for producing over 100 million doses per year of the worldβs...
GlaxoSmithKline and Pfizer, the two of the biggest pharmaceutical companies, has announced a merger of their consumer healthcare units that produce over-the-counter medicines. GSK informed...
Competition Commission of India has accorded its approval to the proposed acquisition of drug maker Pfizer’s manufacturing plant by Ahmedabad-based Vidhi Research and Development LLP....
Pfizer joins hands with IIT-Delhi for providing financial support to Indians and start-ups for initiatives related to health care innovation. ‘Pfizer IIT Delhi innovation and...